Caribou Biosciences, Inc.
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead…
Biotechnology
US, Berkeley [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Caribou Biosciences, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDCaribou Biosciences, Inc. can't present revenue by segment